Ningbo Rong'an Biological Pharmaceutical

Ningbo Rong'an Biological Pharmaceutical is a prominent Chinese biotechnology company specializing in the development and large-scale manufacturing of human vaccines. As a core subsidiary of Aim Vaccine, the company is a market leader in China for its Human Rabies Vaccine (Vero Cell), which is used for post-exposure prophylaxis. The company operates advanced manufacturing facilities in Ningbo that comply with national GMP standards, ensuring high-quality production of biological products. Beyond its commercial rabies vaccine, Rong'an is heavily involved in the R&D of next-generation vaccine technologies, including mRNA-based rabies vaccines and freeze-dried formulations. The company plays a critical role in the public health infrastructure of China by providing essential immunization products against infectious diseases.